Tumor cells exploit platelet-mediated GITR activation through two complementary mechanisms: direct translocation of platelet-derived GITRL to tumor membranes, and upregulation of platelet-constitutive GITRL expression during tumor-induced activation [50, 51]. The gene discussed is TNFRSF18; the disease is neoplasm.